The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular and clinical profiling of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs): An analysis of the Oncology Research Information Exchange Network database.
 
Benjamin Ueberroth
No Relationships to Disclose
 
Hannah Robinson
Research Funding - Genentech (Inst)
 
S. Lindsey Davis
Stock and Other Ownership Interests - Johnson & Johnson/MedTech
Speakers' Bureau - Allergan (I)
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); I-Mab (Inst); Merck (Inst); ORIC Pharmaceuticals (Inst); Seagen (Inst); Symphogen (Inst); TriSalus Life Sciences (Inst); Tvardi Therapeutics (Inst)
 
Christopher Lieu
Consulting or Advisory Role - Amgen (Inst)
Research Funding - Genentech (Inst)
 
Nicole Balmaceda
No Relationships to Disclose
 
Alexander Hayden
No Relationships to Disclose
 
Alexis Leal
Employment - Elsevier
Leadership - Elsevier
Honoraria - MedPro Specialty Advisory Board
Research Funding - Abbvie (Inst); Antengene (Inst); Arrys Therapeutics (Inst); Bristol-Myers Squibb (Inst); Conjupro Biotherapeutics (Inst); Corcept Therapeutics (Inst); Elicio Therapeutics (Inst); Exelixis (Inst); FameWave Ltd. (Inst); Hutchison MediPharma (Inst); Takeda (Inst)
 
Sunnie Kim
Honoraria - Merck
Consulting or Advisory Role - Astellas Pharma; Daiichi Sankyo/Lilly; I-Mab
Research Funding - Merck
 
Robert Lentz
Consulting or Advisory Role - Agenus (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Natera (Inst)
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Experimental Drug Development Centre (EDDC)/A*STAR (Inst); Guardant Health (Inst); Lilly (Inst); Merck (Inst)
 
Wells Messersmith
Honoraria - Research to Practice (Inst)
Consulting or Advisory Role - Amgen; Criterium (Inst)
Research Funding - Agenus (Inst); ALX Oncology (Inst); AstraZeneca/MedImmune (I); Beigene (Inst); CanBas (Inst); Exelixis (Inst); Experimental Drug Development Centre (EDDC); FATE Therapeutics (Inst); Mirati Therapeutics (Inst); Nurix (Inst); Pfizer (Inst); PureTech (Inst); RasCal (Inst); Revolution Medicines (Inst)
 
Emily Baiyee Toegel
No Relationships to Disclose